LSE:DDDD (4d Pharma Plc)
About DDDD
4D Pharma Plc is a pharmaceutical company, which engages in the development of live bio therapeutics. It focuses on the research of Microbiome, MicroRx, and MicroDx its proprietary platforms for the discovery of novel live bio therapeutics and the development of its pipeline. The company was founded by Duncan Joseph Peyton on January 10, 2014 and is headquartered in Leeds, the United Kingdom.
4d Pharma Plc (LSE: DDDD) Latest News
Investing Articles
Here’s why the 4D Pharma (LON:DDDD) share price is surging today
Investing Articles
4D Pharma shares have rocketed and I’m tempted to buy now
Investing Articles
This penny stock could double in just 2 years
Investing Articles
3 trending penny shares: hit, hold or fold?
Investing Articles
Interested in the 4d Pharma share price? Here’s what you need to know
Investing Articles
Covid-19 drug maker’s share price triples! Here’s what I’m doing now
Investing Articles
4D pharma share price spiked under COVID-19 phase II study spotlight
Investing Articles
3 Neil Woodford stocks trading at massive discounts
Investing Articles
Are these two hot biotechnology shares to buy today?
Investing Articles
Should you buy Neil Woodford’s favourite small caps Purplebricks Group plc, 4d Pharma plc and Imperial Innovations Group plc?
Investing Articles
Why is Neil Woodford so bullish on drugmakers GlaxoSmithKline plc, AstraZeneca plc and 4D Pharma plc?
Investing Articles
Neil Woodford Buys More ‘Profoundly Undervalued’ Allied Minds PLC, 4d Pharma PLC And Midatech Pharma PLC
1❯